Esta web utiliza cookies propias y de terceros que nos permiten optimizar tu experiencia en el sitio web, evaluar su rendimiento, generar estadísticas de uso y mejorar y añadir nuevas funcionalidades. Mediante el análisis de tus hábitos de navegación podemos mostrar contenidos más relevantes y medir las interacciones con la web.
Puede obtener más información aquí.

Avanzado
Artículos
Portada

A CAMELOT OF THE BIOMEDICAL SCIENCES IBD

DAVID FISHER / HERBERT WEISSBACH
RIMB ADVENTURES
10 / 2016
9780998278407
Inglés

Sinopsis

A Camelot of the Biomedical Sciencesá The Story of the Roche Institute of Molecular Biology á á á á á á á á á áá á á á áá á á The history of science began with wonder. Its foundation was endless curiosity about the world and people brave enough to ask, what if? How? And why? It began in rudimentary laboratories set up by wealthy men in basements and emptied rooms. The British Royal Academy gave it a formal experimental structure. And for almost two centuries it was the exclusive domain of those wealthy and educated people able to find the time and resources to conduct their experiments. To satisfy their own curiosity. á á áThe experimental laboratory is a relatively new invention, established mostly in universities before 1900. But laboratory science began growing with the realization that discoveries made in the lab could become valuable products. Edison proved those things discovered in laboratories had substantial commercial value. In the biomedical field two distinct industries came into creation: the prestigious laboratories and Universities where research was done to expand knowledge and commercial laboratories where it was done for profit. For decades, as the world&rsquo,s pharmaceutical industry developed and prospered in the United States, they remained separate and distinct. And then, in 1967, one of theworld&rsquo,s pharmaceutical corporations, Hoffmann- La Roche changed that world, it created and funded a laboratory for pure scientific research. There had never before been anything like it in the pharmaceutical industry. á á áAnd this is the extraordinary story of the Roche Institute of Molecular Biology, told in the words of the people who created it. á á áWith its substantial profits, especially from the psychopharm- acologic drugs librium and valium, staid Hoffmann-La Roche decided to make a ubstantial investment in the future: It would establish a place where many of the best scientists in the world could work on projects of their own creation -- with guaranteed funding and no requirements to produce results &ndash, much less a product. It was a scientific Camelot. Roche began by recruiting several of the most respected scientists at the prestigious National Institutes of Health. The first two men to risk their careers by joining the as-yet nonexistent Roche Institute, Sidney Udenfriend and Herbert Weissbach, with the support of senior management at Hoffmann-La Roche, would build a dream into a world renowned scientific research center. á á áBy the time the Roche Institute closed its doors, a victim of the biotech revolution that resulted in numerous entrepreneurial start-ups funded by Wall Street dollars, its scientists had made significant contributions to biomedical research while training many of the next generations of great research scientists. The staff eventually included one Nobel Prize recipient and seven elected members of the National Academy of Science. And equally important, the institute had laid the path that Roch

PVP
30,85€